about
Deregulation of the activin/follistatin system in hepatocarcinogenesisN-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.A bicistronic baculovirus vector for transient and stable protein expression in mammalian cells.Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR/AKT/mTOR pathway.The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells.Stable protein expression in mammalian cells using baculoviruses.Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.Use of four new human-derived liver-cell lines for the detection of genotoxic compounds in the single-cell gel electrophoresis (SCGE) assay.In vitro anti-inflammatory and anticancer activities of extracts of Acalypha alopecuroidea (Euphorbiaceae).Microscopic analysis of adenoviral decontamination using GFP adenovirus with comparable sensitivity to flow cytometry.Indications for cell stress in response to adenoviral and baculoviral gene transfer observed by proteome profiling of human cancer cells.Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells
P50
Q28260262-F55BCE76-2787-40BD-9A98-73E95D4791D8Q33301354-5EE455FC-850C-4C2E-A739-EC369F0E2096Q34785518-769E1DFF-80E7-47BC-899E-90251DCF1FC3Q34806721-9096BF85-5D78-471E-BE00-7D6BDF7BA0B7Q39110541-A123744C-BC95-489C-AD89-E93EF43FAAF1Q39388106-AB5100CD-982D-4A2C-80D3-21E4FF2FAD53Q39409582-D860BB4C-EC8F-45A4-AC63-9E13A1F682D5Q39460346-0E024446-451D-4C52-A569-C01B5D59D538Q39884554-BBB43E17-89F5-4BE7-96AB-46B8E00AE281Q39940273-EA293663-C738-40C4-876A-63E0C7A02C06Q43282213-4039B3C3-1FD0-4EAA-83AF-93CB7081D721Q44128056-D4FF4AEA-91C9-4AE5-B07C-A6B1F4156E46Q44704166-F9BE8E34-5093-43BE-8A9E-0BE48D9F1AB9Q46326805-2EDAC73E-767D-49B9-A5E2-985F50DF8593Q52971139-3BAAAED2-0A4E-4ABF-9832-868A62E677B8Q57909838-81D6F215-3BDD-407B-9C37-6FDAAB092882
P50
description
researcher ORCID ID = 0000-0003-1168-7947
@en
wetenschapper
@nl
name
Andreas Lackner
@ast
Andreas Lackner
@en
Andreas Lackner
@es
Andreas Lackner
@nl
type
label
Andreas Lackner
@ast
Andreas Lackner
@en
Andreas Lackner
@es
Andreas Lackner
@nl
prefLabel
Andreas Lackner
@ast
Andreas Lackner
@en
Andreas Lackner
@es
Andreas Lackner
@nl
P106
P31
P496
0000-0003-1168-7947